• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥洛穆茨大学医院第一外科食管癌的手术治疗结果

Esophageal cancer results of surgical treatment at the Department of Surgery I. at the University Hospital Olomouc.

作者信息

Vrba R, Aujeský R, Stašek M, Vomáčková K, Tesaříková J, Hlaváčková L, Cincibuch J, Vrána D, Horáková M, Zapletalová J, Neoral Č

出版信息

Rozhl Chir. 2018 Winter;97(7):342-348.

PMID:30634851
Abstract

The authors present the results of surgical treatment of esophageal cancer at Department of Surgery I, University Hospital Olomouc between 20062016. The aim of the study was to use retrospective analysis to evaluate the results of patients operated for esophageal cancer and statistically evaluate the results based on the type of surgical approach (transhiatal, transthoracic). Method: A total of 240 patients with esophageal cancer were operated at Department of Surgery I between the beginning of 2006 and the end of 2016. We evaluated respiratory complications, the incidence of anastomotic fistula and complications based on the Clavien-Dindo classification of complications, based on the type of surgical approach selected (transhiatal or transthoracic esophagectomy). Results: The patient set included 207 men (86.3%) and 33 women (13.7%). The mean patient age was 60.4 years. The histological type was adenocarcinoma in 145 (60.4%) and squamous cell carcinoma in 90 (37.5%) patients; another type of carcinoma was observed in 5 cases. Transhiatal esophagectomy was performed in 194 patients (80.2%) (transhiatal laparoscopic in 190 and classic Orringer in 4 patients). Transthoracic approach was used in 46 patients (19.2%), thoracoscopic in 16, and thoracotomic in 30 patients. A gastric conduit was used in 236 patients and coloplasty was performed in 4 patients. The mean duration of surgery was 217 min for the transhiatal approach, 239 min for the thoracoscopic approach and 277 min for the thoracotomic approach. Total blood loss per patient was 562 ml on average for all the operated patients. Peri- or postoperative blood transfusions were administered to 148 patients. Lymphadenectomy was performed as part of the procedure in all patients; the mean of 16.1 lymph nodes were removed. The average hospital stay was 20.7 days. In the patient set, 30-day mortality included 12 patients (respiratory complications 10, MI 1, conduit necrosis 1) and 90-day mortality included 4 (multi organ failure during ARDS). Based on statistical analysis, the incidence of respiratory complications significantly correlated with ASA classification (p=0.0001) and Clavien-Dindo classification (p.

摘要

作者展示了2006年至2016年期间奥洛穆茨大学医院第一外科对食管癌进行手术治疗的结果。本研究的目的是通过回顾性分析评估接受食管癌手术患者的结果,并根据手术方式(经裂孔、经胸)对结果进行统计学评估。方法:2006年初至2016年底,共有240例食管癌患者在第一外科接受手术。我们根据所选手术方式(经裂孔或经胸食管癌切除术),评估了呼吸并发症、吻合口瘘的发生率以及基于Clavien-Dindo并发症分类的并发症情况。结果:患者组包括207名男性(86.3%)和33名女性(13.7%)。患者平均年龄为60.4岁。组织学类型为腺癌的有145例(60.4%),鳞状细胞癌的有90例(37.5%);另外5例为其他类型的癌。194例患者(80.2%)接受了经裂孔食管癌切除术(190例为经裂孔腹腔镜手术,4例为经典的奥林格手术)。46例患者(19.2%)采用经胸手术方式,其中16例为胸腔镜手术,30例为开胸手术。236例患者使用了胃管道,4例患者进行了结肠成形术。经裂孔手术的平均手术时长为217分钟,胸腔镜手术为239分钟,开胸手术为277分钟。所有接受手术患者的平均每人总失血量为562毫升。148例患者接受了围手术期或术后输血。所有患者手术过程中均进行了淋巴结清扫;平均清扫淋巴结16.1枚。平均住院时间为20.7天。在患者组中,30天死亡率包括12例患者(呼吸并发症10例、心肌梗死1例、管道坏死1例),90天死亡率包括4例(急性呼吸窘迫综合征期间多器官功能衰竭)。基于统计分析,呼吸并发症的发生率与美国麻醉医师协会(ASA)分级(p = 0.0001)和Clavien-Dindo分级(p...

相似文献

1
Esophageal cancer results of surgical treatment at the Department of Surgery I. at the University Hospital Olomouc.奥洛穆茨大学医院第一外科食管癌的手术治疗结果
Rozhl Chir. 2018 Winter;97(7):342-348.
2
Hybrid thoracoscopic esophagectomy for cancer - retrospective analysis and comparison with transhiatal resection.杂交胸腔镜食管癌切除术治疗癌症——回顾性分析及与经裂孔切除术的比较
Rozhl Chir. 2018 Spring;97(7):320-327.
3
Complications and mortality of surgical therapy for esophageal cancer: 10 years single center experience.食管癌外科治疗的并发症和死亡率:10 年单中心经验。
Neoplasma. 2018 Sep 19;65(5):799-806. doi: 10.4149/neo_2018_171013N651. Epub 2018 Jun 17.
4
Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer.单孔纵隔镜辅助经裂孔食管癌切除术治疗胸段食管癌的围手术期结果
Dis Esophagus. 2017 Oct 1;30(10):1-8. doi: 10.1093/dote/dox047.
5
Limited operation for patients with T1 esophageal cancer.T1期食管癌患者的有限手术。
Langenbecks Arch Surg. 2000 Nov;385(7):454-8. doi: 10.1007/s004230000173.
6
Transthoracic approach is associated with increased incidence of atrial fibrillation after esophageal resection.经胸入路与食管切除术后房颤发生率增加有关。
Surg Endosc. 2015 Jul;29(7):2039-45. doi: 10.1007/s00464-014-3908-9. Epub 2014 Nov 1.
7
Transhiatal esophageal surgery for malignancy--a 7-year experience at a tertiary care hospital.经胸食管恶性肿瘤手术——一家三级医院的7年经验
J Coll Physicians Surg Pak. 2009 Jul;19(7):413-6.
8
Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival.在发病率、死亡率和生存率方面,开放性经胸或经裂孔食管切除术与微创食管切除术的比较
Surg Endosc. 2006 Nov;20(11):1681-6. doi: 10.1007/s00464-006-0009-4. Epub 2006 Sep 6.
9
Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery.非开胸入路机器人根治性食管癌切除术与传统开胸手术相比的短期疗效
Dis Esophagus. 2016 Jul;29(5):429-34. doi: 10.1111/dote.12345. Epub 2015 Mar 23.
10
Gasless laparoscopically assisted transhiatal esophagectomy for upper esophageal carcinoma.无气腹腔镜辅助经裂孔食管癌切除术治疗上段食管癌
Ann Surg Oncol. 2015 Mar;22(3):1015-9. doi: 10.1245/s10434-014-4035-5. Epub 2014 Sep 18.

引用本文的文献

1
Hybrid esophagectomy for oesophageal cancer: long-term results. A single-centre experience.食管癌的杂交食管切除术:长期结果。单中心经验。
Wideochir Inne Tech Maloinwazyjne. 2021 Jun;16(2):297-304. doi: 10.5114/wiitm.2020.100893. Epub 2020 Nov 16.
2
TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?经胸食管切除术治疗食管鳞癌:最佳适应证是什么?
Arq Bras Cir Dig. 2021 Mar 22;33(4):e1567. doi: 10.1590/0102-672020200004e1567. eCollection 2021.